ArticleOncotarget2018

Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells.

Vineela Chukkapalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.